The present invention relates to a compound represented by the formula:
wherein A is pyridyl group having at least one substituent
wherein R
1
, R
2
and R
3
are each a hydrogen atom, a halogen atom, a C
1-6
alkyl group optionally substituted by halogen or a C
1-6
alkoxy group optionally substituted by halogen, R
4
and R
6
are each a hydrogen atom, a halogen atom or a C
1-6
alkyl group optionally substituted by halogen, R
5
is a hydrogen atom, a halogen atom, a C
1-6
alkyl group optionally substituted by halogen or a C
1-6
alkoxy group optionally substituted by halogen, and R
7
is a hydrogen atom or a C
1-6
alkyl group optionally substituted by halogen or a salt thereof, or a pharmaceutical composition containing the same.
本发明涉及一种由以下式表示的化合物:其中A是含有至少一个取代基的
吡啶基,其中R1、R2和R3均为氢原子、卤素原子、C1-6烷基(可选地被卤素取代)或C1-6烷氧基(可选地被卤素取代),R4和R6均为氢原子、卤素原子或C1-6烷基(可选地被卤素取代),R5为氢原子、卤素原子、C1-6烷基(可选地被卤素取代)或C1-6烷氧基(可选地被卤素取代),R7为氢原子或C1-6烷基(可选地被卤素取代)或其盐,或包含该化合物的药物组合物。